Akio
Kamimura
*,
Toshiyuki
Tanaka
,
Masahiro
So
,
Tomoyuki
Itaya
,
Kantaro
Matsuda
and
Takuji
Kawamoto
Department of Applied Molecular Bioscience, Graduate School of Medicine, Yamaguchi University, Ube 755-8611, Japan. E-mail: ak10@yamaguchi-u.ac.jp
First published on 1st August 2016
A regioselective double Stille coupling reaction was explored using bicyclic stannolanes that were easily prepared from the radical cascade reaction of β-amino-α-methylene esters. Various 1-bromo-2-iodoarenes underwent the double coupling reaction to afford benzoisoindole derivatives in a regioselective manner, where the carbon attached to the iodine selectively coupled with the vinylic carbon, and then the carbon attached to bromine coupled with the alkyl carbon. The combination of intra- and intermolecular coupling reactions provided hexahydroindeno[1,2-b]pyrrole derivatives in good yields. The yields were further improved in the presence of excess amounts of CsF. An attempt to identify the reaction intermediate was made wherein the decomposition of the stannolanes with aqueous HCl and HBr afforded trigonal bipyramidal (TBP) pentacoordinated tin complexes, as confirmed by microanalyses and 119Sn NMR. Using DCl for the decomposition selectively introduced a deuterium to the E-position of the exomethylene unit. The complexes smoothly underwent the intramolecular Stille coupling reaction in the presence of both a palladium catalyst and DABCO, affording hexahydroindeno[1,2-b]pyrroles in good yields. These results suggest that the double coupling reaction progresses through a TBP tin complex, promoting the second intramolecular coupling reaction between the aryl halide and Csp3–tin bond.
Recently, we developed a one-step synthesis of a bicyclic stannolane through a highly cumulated cascade radical reaction wherein a radical addition–cyclization–substitution occurred in one pot.8 This process prompted us to sequentially develop a new type of double coupling reaction.9 In this study, we report the details of a regioselective double coupling reaction of stannolanes. We also explored the substrate scope of aryl halides and pseudohalides. With our methodology, multicyclic benzoisoindoles10 and hexahydroindeno[1,2-b]pyrroles11 are readily prepared in a few steps from simple compounds. These structures are known to feature in biologically active compounds.12,13 The identity of the intermediate in the double coupling reaction was explored through acidic hydrolysis of the stannolanes to afford pentacoordinated trigonal bipyramidal (TBP) tin complexes.
Entry | X | Y | Additivesa | Time (h) | Temp. (°C) | 2a; yieldb (%) |
---|---|---|---|---|---|---|
a Equivalents in parentheses. b Isolated yield. | ||||||
1 | Cl | Cl | DABCO (3) | 20 | 100 | 0 |
2 | OTf | OTf | DABCO (3), LiCl (2.3) | 24 | 100 | 18 |
3 | OTf | OTf | DABCO (3), CuI (2) | 24 | 80 | 21 |
4 | Br | Br | DABCO (3) | 20 | 100 | 76 |
5 | Br | I | DABCO (3), CsF (5) | 24 | 100 | 44 |
6 | I | I | DABCO (0.2), CsF (3) | 24 | 100 | 79 |
The use of dichlorobenzene did not give any double coupling product 2a (entry 1).14 Ditriflate underwent a slow and sluggish reaction to give 2a in only 18% yield. The yield of 2a was improved to 21% when CuI was used as an additive (entry 3).15 Dibromobenzene gave the coupling product 2a in 76% yield (entry 4) and iodobromobenzene also afforded 2a in 44% yield (entry 5). Diiodobenzene underwent a smooth double coupling reaction to give 2a in 79% yield (entry 6). The addition of CsF was necessary to obtain 2a in good yield. Thus, iodoarenes and bromoarenes are the best candidates for the double coupling reaction.
To investigate the reactivity of the sp2 and sp3 carbon–tin bonds, we attempted to introduce two different aromatic groups to 1a using two equivalents of iodobenzene (Scheme 1). However, we could not obtain 3 under these conditions. This is in contrast to the result that the double coupling product 4a was obtained in 32% yield when 1b was used as the coupling partner. These results clearly indicate that the sp3 carbon–tin bond is less reactive and produces no coupling product with any intermolecular coupling partner. The yield of 4a was improved to 80% when three equivalents of CsF were used in the reaction. With this improvement, the amount of DABCO might be reduced to 20 mol%. Thus, the presence of the fluoride anion is effective in promoting the intramolecular coupling reaction with the sp2 carbon–tin bond as well as the sp3 carbon–tin bond.16
Entry | 1 | Ar | R1 | R2 | 2; yielda (%) | Regioisomeric ratiob |
---|---|---|---|---|---|---|
a Isolated yield. b Determined by integration of 1H NMR spectra. | ||||||
1 | 1a | Ph | Cl | H | 2b; 68 | 94/6 |
2 | 1a | Ph | H | Cl | 2c; 38 | 95/5 |
3 | 1a | Ph | Me | H | 2d; 53 | 95/5 |
4 | 1a | Ph | MeO | H | 2e; 44 | >99/1 |
5 | 1a | Ph | H | OMe | 2f; 51 | >99/1 |
6 | 1a | Ph | NO2 | H | 2g; 63 | 94/6 |
7 | 1a | Ph | H | NO2 | 2h; 38 | 83/17 |
8 | 1a | Ph | CF3 | H | 2i; 58 | 96/4 |
9 | 1a | Ph | H | CF3 | 2j; 54 | 90/10 |
10 | 1c | 2-MeC6H4 | Me | H | 2k; 50 | 95/5 |
11 | 1d | 3-MeOC6H4 | H | NO2 | 2l; 55 | 84/16 |
12 | 1c | 2-MeC6H4 | H | CF3 | 2m; 19 | 98/2 |
13 | 1c | 2-MeC6H4 | Cl | H | 2n; 28 | 87/13 |
14 | 1c | 2-MeC6H4 | H | F | 2o; 35 | 94/6 |
15 | 1d | 3-MeOC6H4 | H | Cl | 2p; 26 | 80/20 |
The double coupling reaction progressed smoothly and products 2 were isolated in moderate to good yields. For example, 1-bromo-4-chloro-2-iodobenzene underwent the double coupling reaction to give 2b in 68% yield (entry 1), whereas the double coupling of 1a with 2-bromo-4-chloro-1-iodobenzene afforded its regioisomer 2c in 38% yield (entry 2). The regioselectivity was estimated by 1H NMR integration to be 94/6 in the formation of 2b and 95/5 in the formation of 2c. Other double couplings with various substituted iodobromobenzenes provided the regioselective formation of benzoisoindole 2. The selectivity ranged from 83/17 to 99/1 and nearly complete regioselective double coupling was achieved. The major and minor isomers formed in the reaction shown in entry 7, 2h and 2g, were inseparable by usual chromatographic methods. The regioselectivity was determined by the first coupling between haloarenes and the sp2-carbon–tin bond site. We expected that the aryl carbon-iodine bond would react faster than the aryl carbon-bromine bond. When the substituent of the dihaloarene is located at the m-position to the aryl–iodine bond site, high regioselectivity (>95/5) was achieved (entries 1, 3, 4, 6, 8, and 10). Conversely, a substituent at the p-position to the aryl–iodine bond affected the selectivity very much. For example, the presence of an electron-withdrawing group such as a nitro or a trifluoromethyl group at the para position to the carbon–iodine bond caused the regioselectivity to slightly decrease to 90/10 or 83/17 (entries 7, 9 and 11), whereas an electron-donating substituent at this position maintained high regioselectivity (entry 5). Thus, the regioselectivity is partially affected by the electronic effect of the substituents on the dihaloarenes.
The number of synthetic methods to prepare the multi-substituted benzoisoindole 2 was limited because it is usually difficult to control the position of substituents during the synthesis of such heterocyclic compounds. However, in the present synthesis, the starting materials 1 were prepared in an optically pure form from simple Michael/Mannich reactions followed by a radical cascade reaction. Thus, this methodology provides a new convenient preparation of benzoisoindoles in a few steps in a highly regioselective manner.
The inter- and intramolecular double coupling reactions of 1b and 1e were examined using various iodobenzenes. The results are summarized in Table 3.
The inter- and intramolecular double coupling reactions progressed smoothly in the presence of iodobenzene and 10 mol% of Pd(PtBu3)2, affording hexahydroindeno[1,2-b]pyrroles 4 in good yields. For example, 4-methoxyiodobenzene underwent the coupling reaction at the vinylic carbon–tin bond site, giving a double coupling product 4b in 68% yield (entry 1). Various substituted iodobenzenes smoothly reacted to give compound 4, except for 4-nitroiodobenzene, which gave a complex mixture (entry 4). Note that all aryl groups derived from iodobenzene were selectively introduced to the E-position of the alkylidene group. Thus, the intermolecular coupling progressed selectively with the retention of the vinylic tin unit configuration. Dimethoxy-substituted stannolane 1e also acted as a good double coupling donor to afford compound 4 in good yield (entries 5–9).
We explored this strategy for the synthesis of tetrasubstituted alkenes from 1f; however, we only obtained compound 4k in 59% yield, and not the desired compound 4l that was expected. This is probably because of the steric hindrance caused by the methyl group at the vinylic position, which prevents the Stille coupling reaction with iodotoluene (Scheme 2).
We then attempted to identify the reaction intermediate of the double coupling reaction. The exposure of stannolane 1g to concentrated HCl resulted in the formation of a pentacoordinated trigonal bipyramidal (TBP) tin complex 6a in 72% yield (Scheme 4).8a,17 We exposed the TBP complex 6a to the standard coupling reaction conditions in the presence of five equivalents of CsF, affording the intermolecular coupling product 7 in 87% yield. To confirm the structure of 7, reduction was performed in the presence of DIBAL-H to give compound 5 in almost quantitative yield. Note that the intramolecular coupling progressed only when CsF was employed in the reaction.
The acidic treatment of 1b also yielded the corresponding TBP complex 6b in 91% yield (Scheme 5). This is supported by the fact that a signal for the OH proton in 6b was observed in the 1H NMR at δ 2.84 (dd, J = 7.9, 3.8 Hz). Microanalysis data indicated that a chlorine atom is contained in 6b. Compound 6b afforded the intramolecular coupling product 5 in 62% yield by treatment with the catalytic amounts of Pd(tBu3P)3 in the presence of DABCO. We believe that the coordination of an oxygen atom to the tin atom promoted the coupling reaction of the alkyl tin unit; however, some basic additive, such as CsF, is necessary to achieve an efficient reaction.9
To obtain further information on the TBP complex, we performed simple acidic decomposition of 1a and analysed the products using NMR and microanalytical studies (Scheme 6). Treatment of 1a with HCl and HBr gave the corresponding products 6c and 6d, respectively, in good yields. There are several observations that should be noted for these compounds. Again, the OH proton signal was observed in the 1H NMR spectra for these compounds. Microanalyses of these compounds indicated that compounds 6c and 6d included a halogen atom. Furthermore, the 119Sn NMR signals of 6c and 6d in CDCl3 appeared at 33.3 and 28.8 ppm, respectively, which are highly up-field shifted compared with those of trialkylchlorotin compounds, such as Bu3SnCl (152.8 ppm in CDCl3),18 but close to the chemical shift of TBP tin complex 6e, which shows a 119Sn NMR peak at 25.4 ppm.8a These results clearly suggested that the hydroxyl groups in compounds 6c and 6d coordinate to the tin atom to form a pentacoordinated tin complex, such as 6e. Unfortunately we have not obtained any crystalline form of compounds 6b to 6d to date, and no further evidence for the complex is available. Note that the bromine atom in compound 6d was replaced by a chlorine or a fluorine atom by treatment with aqueous NaCl or CsF solution. For example, compound 6f was obtained in 85% yield by the simple stirring of a biphasic mixture of 6d in ether and aqueous CsF. We examined the intermolecular Stille coupling reaction of compound 6f with an excess of bromobenzene (10 equiv.). However, a complex mixture was obtained, and no expected products were observed.
Considering these results, we suggest that the reaction mechanism is as follows (Scheme 7): aryliodide reacts with the vinylic carbon–tin bond to afford arylalkene intermediate A, a TBP complex in which the hydroxy group coordinates to a tin atom.16 The aryl group is selectively introduced at the E-position of the exomethylene unit. This intermediate is sufficiently reactive toward the intramolecular reaction by activation in the presence of CsF or DABCO to give the double coupling adduct 2 from bromoiodoarenes or 4 from o-bromoaryl-substituted precursor 1. Conversely, in the intermolecular reaction, intermediate A is less reactive and does not give any intermolecular adduct.
[α]D +33.6 (c 1.83, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.52 (d, J = 8.3 Hz, 2H), 7.18 (d, J = 4.2 Hz, 3H), 7.14 (d, J = 8.1 Hz, 2H), 7.07 (t, J = 7.4 Hz, 1H), 7.11–6.98 (m, 2H), 7.01 (t, J = 7.5 Hz, 1H), 6.95 (d, J = 6.4 Hz, 1H), 6.94 (d, J = 6.1 Hz, 1H), 6.43 (s, 1H), 5.29 (s, 1H), 4.42 (dd, J = 15.1, 2.3 Hz, 1H), 4.33 (dd, J = 15.1, 1.3 Hz, 1H), 3.4–3.6 (br, 1H), 3.26 (d, J = 10.7 Hz, 1H), 3.10 (d, J = 10.7 Hz, 1H), 2.58 (d, J = 16.1 Hz, 1H), 2.35 (s, 3H), 2.08 (d, J = 16.0 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 143.4, 139.9, 139.3, 135.7, 133.2, 132.3, 129.5 (2C), 128.8, 128.5 (2C), 127.5, 127.4, 127.3 (2C), 126.8 (2C), 126.22, 126.21, 122.3, 69.1, 62.0, 53.0, 51.1, 31.8, 21.6; HRMS (ESI-TOF) m/z [M + Na]+ calcd for C26H25NNaO3S 454.1453, found 454.1447.
[α]D +47.2 (c 1.79, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.51 (d, J = 8.3 Hz, 2H), 7.22–7.17 (m, 3H), 7.15 (d, J = 7.9 Hz, 2H), 7.09–7.00 (m, 2H), 6.98 (dd, J = 8.0, 2.2 Hz, 1H), 6.94 (d, J = 2.1 Hz, 1H), 6.86 (d, J = 8.2 Hz, 1H), 6.37 (d, J = 2.0 Hz, 1H), 5.25 (s, 1H), 4.42 (dd, J = 15.3, 2.4 Hz, 1H), 4.33 (dd, J = 15.3, 1.7 Hz, 1H), 3.23 (dd, J = 10.6, 4.7 Hz, 1H), 3.08 (ddd, J = 10.6, 5.9, 1.5 Hz, 1H), 2.53 (d, J = 16.1 Hz, 1H), 2.36 (s, 3H), 1.99 (dd, J = 15.9, 1.5 Hz, 1H), 1.70–1.64 (m, 1H); 13C NMR (126 MHz, CDCl3) δ 143.4, 141.1, 139.6, 135.6, 133.9, 132.2, 131.5, 129.9, 129.5 (2C), 128.5 (2C), 128.1–127.4 (br, 2C), 127.6, 127.3 (2C), 127.2, 126.0, 121.3, 69.0, 61.9, 53.1, 50.9, 31.2, 21.6; HRMS (ESI-TOF) m/z [M + Na]+ calcd for C26H24ClNNaO3S 488.1063, found 488.1055.
[α]D +6.6 (c 1.12, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.53 (d, J = 8.2 Hz, 2H), 7.24–7.18 (m, 3H), 7.16 (d, J = 7.7 Hz, 2H), 7.11–6.98 (m, 2H), 7.05 (dd, J = 8.1, 2.1 Hz, 2H), 6.94 (s, 1H), 6.88 (d, J = 8.1 Hz, 1H), 6.41 (s, 1H), 5.25 (s, 1H), 4.41 (dd, J = 15.3, 2.4 Hz, 1H), 4.34 (dd, J = 15.0, 1.2 Hz, 1H), 3.23 (dd, J = 10.6, 4.4 Hz, 1H), 3.07 (dd, J = 11.0, 5.3 Hz, 1H), 2.53 (d, J = 16.2 Hz, 1H), 2.37 (s, 3H), 2.04 (d, J = 16.9 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 143.4, 139.8, 139.6, 135.6, 135.1, 132.7, 130.8, 129.5 (2C), 128.9, 128.5 (2C), 128.0–127.4 (br, 2C), 127.6, 127.3 (2C), 127.2, 126.8, 121.4, 69.0, 61.9, 52.8, 50.9, 31.7, 21.6; HRMS (ESI-TOF) m/z [M + H]+ calcd for C26H25ClNO3S 466.1244, found 466.1253.
[α]D +12.0 (c 0.53, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.54–7.45 (m, 2H), 7.23–7.17 (m, 3H), 7.17–7.13 (m, 2H), 7.10–6.97 (m, 2H), 6.84–6.81 (m, 2H), 6.77 (d, J = 1.5 Hz, 1H), 6.39 (t, J = 2.0 Hz, 1H), 5.24 (s, 1H), 4.40 (dd, J = 15.1, 2.4 Hz, 1H), 4.32 (dd, J = 15.2, 1.6 Hz, 1H), 3.26 (dd, J = 10.7, 4.6 Hz, 1H), 3.07 (dd, J = 9.4, 5.2 Hz, 1H), 2.48 (d, J = 16.0 Hz, 1H), 2.36 (s, 3H), 2.23 (s, 3H), 2.09–1.95 (m, 1H), 1.54 (s, 1H); 13C NMR (126 MHz, CDCl3) δ 143.3, 139.9, 139.2, 136.3, 135.7, 132.1, 130.0, 129.4 (2C), 128.6, 128.4 (2C), 128.1, 128.0–127.4 (br, 2C), 127.4, 127.3 (2C), 127.1, 122.4, 69.1, 62.1, 53.1, 50.9, 31.4, 21.6, 21.0; HRMS (ESI-TOF) m/z [M + Na]+ calcd for C27H27NNaO3S 468.1609, found 468.1600.
[α]D −55.5 (c 1.62, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.52 (d, J = 8.2 Hz, 2H), 7.24–7.17 (m, 3H), 7.15 (d, J = 8.5 Hz, 2H), 7.12–7.01 (m, 2H), 6.85 (dd, J = 8.3, 1.0 Hz, 1H), 6.57 (dd, J = 8.2, 2.7 Hz, 1H), 6.53 (d, J = 2.7 Hz, 1H), 6.39 (t, J = 2.1 Hz, 1H), 5.24 (s, 1H), 4.40 (dd, J = 15.2, 2.4 Hz, 1H), 4.33 (dd, J = 15.1, 1.7 Hz, 1H), 3.72 (s, 3H), 3.26 (dd, J = 10.6, 4.4 Hz, 1H), 3.05 (dd, J = 11.0, 6.8 Hz, 1H), 2.46 (d, J = 15.9 Hz, 1H), 2.36 (s, 3H), 1.99 (dt, J = 15.7, 1.4 Hz, 1H), 1.54 (dd, J = 6.0, 4.7 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 158.5, 143.3, 140.1, 139.9, 135.7, 133.3, 129.5 (2C), 129.4, 128.4 (2C), 127.7, 127.5, 127.3 (2C), 125.0 (2C), 122.3, 112.3, 112.2, 69.1, 62.1, 55.4, 53.3, 50.9, 30.9, 21.6; HRMS (ESI-TOF) m/z [M + Na]+ calcd for C27H27NNaO4S 484.1559, found 484.1562.
[α]D −31.8 (c 0.02, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.52 (d, J = 8.2 Hz, 2H), 7.19 (d, J = 5.5 Hz, 3H), 7.15 (d, J = 8.0 Hz, 2H), 7.11–6.95 (m, 2H), 6.88 (d, J = 8.3 Hz, 1H), 6.60 (dd, J = 8.3, 2.6 Hz, 1H), 6.53 (d, J = 2.5 Hz, 1H), 6.38 (t, J = 2.2 Hz, 1H), 5.26 (s, 1H), 4.39 (dd, J = 15.0, 2.4 Hz, 1H), 4.32 (dd, J = 15.0, 1.6 Hz, 1H), 3.69 (s, 3H), 3.26 (d, J = 10.6 Hz, 1H), 3.07 (d, J = 10.7 Hz, 1H), 2.53 (d, J = 16.1 Hz, 1H), 2.36 (s, 3H), 2.09–2.02 (m, 1H), 1.87 (s, 1H); 13C NMR (126 MHz, CDCl3) δ 159.0, 143.3, 140.0, 136.3, 135.7, 135.0, 129.4 (2C), 128.5 (2C), 128.0–127.6 (br, 2C), 127.4, 127.3 (2C), 127.2, 125.4, 121.8, 115.0, 111.5, 69.1, 62.0, 55.3, 52.8, 50.9, 32.3, 21.6; HRMS (ESI-TOF) m/z [M + H]+ calcd for C27H28NO4S 462.1739, found 462.1728.
[α]D +56.4 (c 1.57, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.86 (dt, J = 8.4, 2.3 Hz, 1H), 7.80 (dd, J = 2.4, 1.3 Hz, 1H), 7.50 (d, J = 7.2 Hz, 2H), 7.25–7.18 (m, 3H), 7.15 (d, J = 8.5 Hz, 2H), 7.09 (d, J = 8.0 Hz, 1H), 7.07–6.97 (m, 2H), 6.51 (t, J = 1.9 Hz, 1H), 5.30 (s, 1H), 4.47 (ddd, J = 15.9, 2.5, 1.0 Hz, 1H), 4.43–4.30 (m, 1H), 3.21 (d, J = 10.6 Hz, 1H), 3.17 (d, J = 10.6 Hz, 1H), 2.75 (d, J = 16.6 Hz, 1H), 2.36 (s, 3H), 2.09 (d, J = 17.7 Hz, 1H), 1.90–1.76 (m, 1H); 13C NMR (126 MHz, CDCl3) δ 147.1, 143.6, 142.7, 141.1, 139.2, 135.5, 133.6, 129.5 (2C), 129.4, 128.7 (2C), 127.8, 127.7–127.3 (br, 2C), 127.2 (2C), 122.3, 120.9, 120.6, 68.9, 62.1, 53.0, 50.8, 32.0, 21.6; HRMS (ESI-TOF) m/z [M + Na]+ calcd for C26H24N2NaO5S 499.1304, found 499.1308.
[α]D −16.6 (c 1.16, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.94 (dd, J = 8.4, 2.3 Hz, 1H), 7.83 (d, J = 2.2 Hz, 1H), 7.53 (d, J = 8.0 Hz, 2H), 7.24–7.19 (m, 3H), 7.16 (d, J = 8.0 Hz, 2H), 7.08 (d, J = 8.5 Hz, 1H), 7.05–6.93 (m, 2H), 6.60–6.47 (m, 1H), 5.31 (s, 1H), 4.47 (dd, J = 15.9, 2.5 Hz, 1H), 4.39 (dd, J = 16.0, 1.6 Hz, 1H), 3.21 (d, J = 10.8 Hz, 1H), 3.13 (d, J = 10.8 Hz, 1H), 2.72 (d, J = 16.2 Hz, 1H), 2.36 (s, 3H), 2.09 (d, J = 16.3 Hz, 1H), 1.77–1.68 (m, 1H); 13C NMR (126 MHz, CDCl3) δ 146.6, 145.2, 143.6, 139.2, 138.5, 135.5, 134.8, 129.5 (2C), 128.7 (2C), 127.8 (2C), 127.3 (2C), 127.4–127.1, 126.4, 123.8, 122.6, 121.1, 76.9, 68.9, 62.0, 52.9, 51.1, 31.7, 21.6; HRMS (ESI-TOF) m/z [M + Na]+ calcd for C26H24N2NaO5S 499.1304, found 499.1294.
[α]D +38.2 (c 1.45, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.51 (d, J = 8.0 Hz, 2H), 7.26 (d, J = 7.6 Hz, 1H), 7.23–7.18 (br, 5H), 7.15 (d, J = 8.0 Hz, 2H), 7.05 (d, J = 7.8 Hz, 2H), 6.47 (s, 1H), 5.29 (s, 1H), 4.46 (d, J = 15.4 Hz, 1H), 4.35 (d, J = 15.3 Hz, 1H), 3.23 (d, J = 10.6 Hz, 1H), 3.15 (d, J = 10.7 Hz, 1H), 2.67 (d, J = 16.3 Hz, 1H), 2.36 (s, 3H), 2.18–2.14 (br, 1H), 2.08 (d, J = 16.3 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 143.5, 141.5, 139.5, 137.3, 135.6, 132.9, 129.5 (2C), 129.2 (d, J = 32.3 Hz), 129.0, 128.6 (2C), 127.7, 128.0–127.5 (br, 2C) 127.3 (2C), 124.1 (q, J = 272.0 Hz), 124.1 (q, J = 3.8 Hz), 122.7 (q, J = 3.8 Hz), 121.4, 68.9, 62.0, 52.9, 50.9, 31.7, 21.6; HRMS (ESI-TOF) m/z [M + Na]+ calcd for C27H24F3NNaO3S 522.132, found 522.1339.
[α]D +30.8 (c 1.93, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.53 (d, J = 8.3 Hz, 2H), 7.32 (ddd, J = 7.8, 1.9, 0.9 Hz, 1H), 7.24–7.17 (m, 5H), 7.16 (dd, J = 7.8, 0.9 Hz, 2H), 7.04 (d, J = 7.8 Hz, 2H), 6.48 (d, J = 1.9 Hz, 1H), 5.30 (s, 1H), 4.45 (d, J = 14.1 Hz, 1H), 4.37 (dd, J = 15.7, 1.9 Hz, 1H), 3.23 (dd, J = 10.7, 4.7 Hz, 1H), 3.11 (dd, J = 10.7, 5.5 Hz, 1H), 2.66 (d, J = 16.3 Hz, 1H), 2.36 (s, 3H), 2.26–2.11 (m, 1H), 2.07 (d, J = 16.2 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 143.5, 142.5, 139.5, 135.5 (2C), 133.9, 129.5 (2C), 129.2 (q, J = 32.2 Hz), 128.6 (2C), 127.8–128.5 (br, 2C), 127.7, 127.3 (2C), 126.2, 125.5 (q, J = 3.6 Hz), 124.1 (q, J = 272.1 Hz), 123.9 (q, J = 4.2 Hz), 121.4, 68.9, 61.9, 53.0, 51.0, 31.7, 21.6; HRMS (ESI-TOF) m/z [M + H]+ calcd for C27H25F3NO3S 500.1507, found 500.1513.
[α]D +63.2 (c 1.47, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.45 (d, J = 7.8 Hz, 2H), 7.08 (d, J = 8.0 Hz, 2H), 7.04 (d, J = 7.6 Hz, 1H), 6.97 (t, J = 7.4 Hz, 1H), 6.83 (t, J = 7.5 Hz, 1H), 6.75 (s, 2H), 6.70 (d, J = 6.1 Hz, 3H), 6.32 (s, 1H), 5.55 (s, 1H), 4.35 (d, J = 15.0 Hz, 1H), 4.26 (d, J = 15.0 Hz, 1H), 3.20 (d, J = 10.5 Hz, 1H), 3.02 (d, J = 10.5 Hz, 1H), 2.50 (d, J = 15.9 Hz, 1H), 2.39 (s, 3H), 2.35–2.30 (m, 1H), 2.29 (s, 3H), 2.15 (s, 3H), 2.01 (d, J = 15.9 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 143.3, 139.2, 138.4, 136.3, 135.9, 135.7, 132.1, 130.4, 130.0, 129.4 (2C), 128.6, 128.1, 127.7, 127.3 (2C), 127.1, 127.0, 126.2, 122.5, 64.8, 62.2, 53.6, 51.0, 30.2, 21.6, 21.0, 19.7; HRMS (ESI-TOF) m/z [M + Na]+ calcd for C28H29NNaO3S 482.1766, found 482.1765.
[α]D −47.1 (c 0.28, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.93 (d, J = 8.2 Hz, 1H), 7.83 (s, 1H), 7.53 (d, J = 8.1 Hz, 2H), 7.16 (d, J = 8.0 Hz, 2H), 7.14–7.09 (m, 1H), 7.07 (d, J = 8.3 Hz, 1H), 6.95–6.40 (br, 1H), 6.73 (d, J = 8.4 Hz, 1H), 6.50 (s, 1H), 5.27 (s, 1H), 4.46 (d, J = 16.3 Hz, 1H), 4.36 (d, J = 15.8 Hz, 1H), 3.84–3.50 (m, 4H), 3.20 (d, J = 10.7 Hz, 1H), 3.13 (d, J = 10.7 Hz, 1H), 2.75 (d, J = 16.3 Hz, 1H), 2.36 (s, 3H), 2.15–2.06 (m, 1H); 13C NMR (126 MHz, CDCl3) δ 159.7, 146.6, 145.2, 143.6, 140.7, 138.5, 135.4, 134.8, 133.2, 129.7, 129.5 (3C), 127.3 (2C), 126.4, 123.8, 122.5, 121.0, 112.8, 68.8, 61.9, 55.2, 53.0, 51.1, 31.5, 21.6; HRMS (ESI-TOF) m/z [M + H]+ calcd for C27H27N2O6S 507.1590, found 507.1596.
[α]D +60.7 (c 0.68, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.51 (d, J = 8.3 Hz, 2H), 7.26 (d, J = 8.8 Hz, 1H), 7.22–7.01 (m, 6H), 6.91 (t, J = 7.5 Hz, 1H), 6.74 (d, J = 7.8 Hz, 1H), 6.47 (s, 1H), 5.64 (s, 1H), 4.47 (dd, J = 15.4, 2.3 Hz, 1H), 4.36 (dd, J = 15.4, 1.3 Hz, 1H), 3.25 (d, J = 10.5 Hz, 1H), 3.16 (d, J = 10.4 Hz, 1H), 2.72 (d, J = 16.3 Hz, 1H), 2.46 (s, 3H), 2.36 (s, 3H), 2.13 (d, J = 16.2 Hz, 1H), 1.82 (s, 1H); 13C NMR (126 MHz, CDCl3) δ 143.4, 141.5, 138.0, 137.2, 135.8, 132.8, 130.6, 129.4 (2C), 129.4, 129.1, 129.0, 127.5, 127.3, 127.2 (2C), 126.3, 124.6 (q, J = 273.3 Hz), 124.1, 122.7, 121.5, 64.7, 62.1, 53.3, 51.0, 30.6, 21.6, 19.7; HRMS (ESI-TOF) m/z [M + H]+ calcd for C28H27F3NO3S 514.1658, found 514.1663.
[α]D +62.1 (c 0.89, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.51 (d, J = 8.1 Hz, 2H), 7.15 (d, J = 8.1 Hz, 2H), 7.12 (d, J = 7.6 Hz, 1H), 7.06 (t, J = 7.5 Hz, 1H), 6.98 (dd, J = 8.0, 2.0 Hz, 1H), 6.93 (d, J = 1.6 Hz, 1H), 6.91 (d, J = 7.6 Hz, 1H), 6.85 (d, J = 8.0 Hz, 1H), 6.74 (d, J = 7.7 Hz, 1H), 6.38 (s, 1H), 5.62 (s, 1H), 4.44 (dd, J = 15.4, 2.1 Hz, 1H), 4.34 (d, J = 15.5 Hz, 1H), 3.25 (d, J = 10.5 Hz, 1H), 3.13 (d, J = 10.3 Hz, 1H), 2.61 (d, J = 16.0 Hz, 1H), 2.46 (s, 3H), 2.36 (s, 3H), 2.04 (d, J = 16.0 Hz, 1H), 1.78 (s, 1H); 13C NMR (126 MHz, CDCl3) δ 143.4, 141.2, 138.1, 135.8, 135.8, 133.8, 132.2, 131.4, 130.5, 129.9, 129.4 (2C), 127.5, 127.3, 127.2 (2C), 127.2, 126.3, 126.0, 121.5, 64.7, 62.0, 53.5, 51.0, 30.0, 21.6, 19.7; HRMS (ESI-TOF) m/z [M + Na]+ calcd for C27H26ClNNaO3S 502.1220, found 502.1209.
[α]D +79.3 (c 1.13, CHCl3); 1H NMR (500 MHz, CDCl3) δ 77.51 (d, J = 8.2 Hz, 2H), 7.15 (d, J = 8.0 Hz, 2H), 7.12 (d, J = 7.6 Hz, 2H), 7.06 (dd, J = 7.7, 6.9 Hz, 1H), 6.95–6.86 (m, 2H), 6.78–6.71 (m, 2H), 6.66 (d, J = 8.9 Hz, 1H), 6.41 (s, 1H), 5.61 (s, 1H), 4.42 (d, J = 15.0 Hz, 1H), 4.33 (d, J = 15.0 Hz, 1H), 3.26 (d, J = 10.5 Hz, 1H), 3.12 (d, J = 10.5 Hz, 1H), 2.61 (d, J = 16.1 Hz, 1H), 2.45 (s, 3H), 2.36 (s, 3H), 2.10 (d, J = 16.1 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 157.7, 143.3, 139.7, 138.6, 138.2, 135.8, 135.7, 130.5, 129.4 (2C), 127.6, 127.4, 127.3 (2C), 126.2, 124.2, 121.5, 116.1, 116.0, 113.3 (d, J = 21.7 Hz), 64.7, 62.0, 53.1, 50.9, 30.8, 21.6, 19.7; HRMS (ESI-TOF) m/z [M + Na]+ calcd for C27H26FNNaO3S 486.1515, found 486.1506.
[α]D −5.81 (c 1.39, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.52 (d, J = 8.2 Hz, 2H), 7.34–7.24 (m, 1H), 7.21–7.11 (m, 1H), 7.16 (d, J = 8.0 Hz, 2H), 7.04 (d, J = 7.8 Hz, 1H), 6.94 (s, 1H), 6.87 (d, J = 8.0 Hz, 1H), 6.72 (d, J = 7.5 Hz, 1H), 6.67–6.57 (m, 1H), 6.39 (s, 1H), 5.22 (d, J = 12.1 Hz, 1H), 4.41 (d, J = 15.8 Hz, 1H), 4.31 (d, J = 15.0 Hz, 1H), 3.80–3.58 (br, 3H), 3.23 (d, J = 10.5 Hz, 1H), 3.10 (d, J = 10.9 Hz, 1H), 2.55 (d, J = 16.2 Hz, 1H), 2.37 (s, 3H), 2.07 (d, J = 16.2 Hz, 1H), 1.73–1.66 (br, 1H); 13C NMR (126 MHz, CDCl3) δ 143.4, 139.8, 135.7, 135.1, 132.8, 132.7, 130.8, 129.6, 129.4 (2C), 128.9, 127.3, 127.2 (2C), 126.8, 121.4, 120.4, 112.7, 101.5, 101.3, 68.9, 62.0, 55.1, 52.8, 51.0, 31.6, 21.6; HRMS (ESI-TOF) m/z [M + Na]+ calcd for C27H26ClNNaO4S 518.1169, found 518.1181.
[α]D −19.6 (c 0.66, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.87 (d, J = 8.4 Hz, 2H), 7.66 (d, J = 7.3 Hz, 1H), 7.36 (d, J = 8.1 Hz, 2H), 7.25 (dd, J = 18.0, 6.5 Hz, 1H), 7.21 (t, J = 6.6 Hz, 1H), 7.11 (d, J = 7.9 Hz, 2H), 7.02 (d, J = 7.9 Hz, 3H), 6.45 (s, 1H), 5.46 (s, 1H), 4.30 (dd, J = 15.1, 1.9 Hz, 1H), 4.09 (dd, J = 15.2, 2.2 Hz, 1H), 3.48 (d, J = 11.4 Hz, 1H), 3.18 (d, J = 16.5 Hz, 1H), 3.08 (d, J = 11.2 Hz, 1H), 2.87 (d, J = 16.4 Hz, 1H), 2.46 (s, 3H), 2.34 (s, 3H), 1.34–1.24 (m, 1H); 13C NMR (126 MHz, CDCl3) δ 143.9, 141.7, 140.9, 140.6, 137.5, 135.9, 133.1, 129.9 (2C), 129.2 (2C), 128.7 (2C), 128.6, 128.0 (2C), 127.5, 126.6, 124.9, 124.5, 73.0, 64.4, 59.4, 56.0, 38.3, 21.7, 21.2. HRMS (ESI-TOF) m/z [M + H]+ calcd for C27H28NO3S 446.1790, found 446.1798.
[α]D −64.1 (c 0.46, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.90–7.81 (m, 2H), 7.65 (d, J = 7.5 Hz, 1H), 7.35 (d, J = 8.6 Hz, 2H), 7.23 (d, J = 7.5 Hz, 1H), 7.20 (t, J = 7.5 Hz, 1H), 7.06 (d, J = 9.3 Hz, 2H), 7.01 (d, J = 6.8 Hz, 1H), 6.83 (d, J = 8.6 Hz, 2H), 6.42 (s, 1H), 5.44 (s, 1H), 4.28 (dd, J = 15.0, 2.0 Hz, 1H), 4.08 (dd, J = 15.1, 2.0 Hz, 1H), 3.80 (s, 3H), 3.48 (d, J = 11.3 Hz, 1H), 3.18 (d, J = 16.4 Hz, 1H), 3.08 (d, J = 11.3 Hz, 1H), 2.87 (d, J = 16.4 Hz, 1H), 2.45 (s, 3H), 1.71–1.56 (m, 1H); 13C NMR (126 MHz, CDCl3) δ 159.0, 143.9, 141.5, 140.8, 139.7, 135.7, 130.0 (2C), 129.8 (2C), 128.6, 128.2, 127.9 (2C), 127.4, 126.6, 124.6, 124.5, 113.8 (2C), 73.0, 64.4, 59.3, 56.1, 55.4, 38.1, 21.7; HRMS (ESI-TOF) m/z [M + H]+ calcd for C27H28NO4S 462.1739, found 462.1736.
Mp 138.5–139.5 °C; [α]D −37.7 (c 0.56, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.87 (d, J = 7.8 Hz, 2H), 7.65 (d, J = 7.4 Hz, 1H), 7.36 (d, J = 7.8 Hz, 2H), 7.28–7.19 (m, 3H), 7.01 (d, J = 7.2 Hz, 1H), 6.81 (d, J = 8.3 Hz, 1H), 6.71 (d, J = 7.6 Hz, 1H), 6.67 (s, 1H), 6.46 (s, 1H), 5.46 (s, 1H), 4.29 (d, J = 15.1 Hz, 1H), 4.08 (d, J = 15.2 Hz, 1H), 3.78 (s, 3H), 3.47 (d, J = 11.3 Hz, 1H), 3.15 (d, J = 16.3 Hz, 1H), 3.07 (d, J = 11.4 Hz, 1H), 2.87 (d, J = 16.3 Hz, 1H), 2.46 (s, 3H), 1.47–1.43 (m, 1H); 13C NMR (126 MHz, CDCl3) δ 159.5, 143.9, 141.5, 141.3, 140.8, 137.4, 135.7, 129.8 (2C), 129.5, 128.6, 127.9 (2C), 127.4, 126.5, 124.7, 124.4, 121.1, 114.5, 112.8, 72.9, 64.5, 59.5, 55.9, 55.3, 38.3, 21.7; HRMS (ESI-TOF) m/z [M + H]+ calcd for C27H28NO4S 462.1739, found 462.1729.
[α]D −13.8 (c 2.99, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.88 (d, J = 7.6 Hz, 2H), 7.65 (d, J = 6.3 Hz, 1H), 7.36 (d, J = 7.6 Hz, 2H), 7.25 (td, J = 7.2, 1.5 Hz, 1H), 7.21 (t, J = 7.3 Hz, 1H), 7.02 (dd, J = 7.5, 1.2 Hz, 1H), 6.65 (s, 1H), 6.57 (s, 1H), 6.38 (t, J = 1.7 Hz, 1H), 5.40 (s, 1H), 4.30 (dd, J = 15.0, 1.9 Hz, 1H), 4.11 (dd, J = 15.0, 2.0 Hz, 1H), 3.86 (s, 3H), 3.82 (s, 3H), 3.33 (dd, J = 11.2, 4.3 Hz, 1H), 3.11 (d, J = 9.6 Hz, 1H), 3.03 (d, J = 16.4 Hz, 1H), 2.71 (d, J = 16.4 Hz, 1H), 2.45 (s, 3H), 1.92 (s, 3H), 1.61–1.55 (m, 1H); 13C NMR (126 MHz, CDCl3) δ 148.4, 146.5, 143.8, 141.3, 141.0, 140.6, 135.9, 129.8 (2C), 128.7, 128.6, 128.0 (2C), 127.5, 127.2, 126.6, 124.3, 124.1, 113.0, 112.6, 72.7, 64.8, 59.4, 56.2, 55.9, 55.6, 38.6, 21.7, 19.5; HRMS (ESI-TOF) m/z [M + H]+ calcd for C29H32NO5S 506.2001, found 506.1997.
[α]D −71.4 (c 1.76, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.86 (d, J = 7.9 Hz, 2H), 7.35 (d, J = 7.9 Hz, 2H), 7.11 (s, 1H), 7.10 (d, J = 7.9 Hz, 2H), 7.02 (d, J = 7.9 Hz, 2H), 6.51 (s, 1H), 6.44 (s, 1H), 5.41 (s, 1H), 4.31 (d, J = 15.2 Hz, 1H), 4.18–4.07 (m, 1H), 3.87 (s, 3H), 3.80 (s, 3H), 3.47 (d, J = 11.2 Hz, 1H), 3.15 (d, J = 16.1 Hz, 1H), 3.04 (d, J = 11.2 Hz, 1H), 2.82 (d, J = 16.0 Hz, 1H), 2.45 (s, 3H), 2.33 (s, 3H), 1.74–1.61 (m, 1H); 13C NMR (126 MHz, CDCl3) δ 150.0, 149.0, 143.8, 140.8, 137.4, 135.9, 133.2, 133.0, 132.2, 129.8 (2C), 129.1 (2C), 128.7 (2C), 127.9 (2C), 124.5, 108.4, 106.7, 73.6, 64.6, 60.5, 59.7, 56.1, 56.0, 38.6, 21.7, 21.2; HRMS (ESI-TOF) m/z [M + H]+ calcd for C29H32NO5S 506.2001, found 506.2002.
[α]D −52.1 (c 2.00, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.86 (d, J = 7.9 Hz, 2H), 7.35 (d, J = 8.0 Hz, 2H), 7.11 (s, 1H), 7.07 (d, J = 8.4 Hz, 2H), 6.83 (d, J = 8.2 Hz, 2H), 6.51 (s, 1H), 6.41 (s, 1H), 5.40 (s, 1H), 4.30 (d, J = 15.1 Hz, 1H), 4.11 (d, J = 14.9 Hz, 1H), 3.86 (s, 3H), 3.79 (s, 3H), 3.79 (s, 3H), 3.49 (d, J = 11.2 Hz, 1H), 3.16 (d, J = 16.0 Hz, 1H), 3.05 (d, J = 11.2 Hz, 1H), 2.83 (d, J = 16.0 Hz, 1H), 2.44 (s, 3H), 1.37–1.33 (m, 1H); 13C NMR (126 MHz, CDCl3) δ 158.9, 149.9, 149.0, 143.8, 140.0, 135.9, 133.2, 132.3, 130.1 (2C), 129.8 (2C), 128.3, 127.9 (2C), 124.2, 113.8 (2C), 108.3, 106.7, 73.6, 68.2, 64.6, 59.6, 56.0, 56.0, 55.3, 38.3, 21.7; HRMS (ESI-TOF) m/z [M + Na]+ calcd for C29H31NNaO6S 544.1770, found 544.1761.
[α]D −51.4 (c 3.08, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.85 (d, J = 8.0 Hz, 2H), 7.35 (d, J = 7.9 Hz, 2H), 7.21 (t, J = 7.9 Hz, 1H), 7.09 (s, 1H), 6.79 (d, J = 9.2 Hz, 1H), 6.71 (d, J = 7.6 Hz, 1H), 6.67 (s, 1H), 6.51 (s, 1H), 6.44 (s, 1H), 5.41 (s, 1H), 4.30 (d, J = 15.3 Hz, 1H), 4.11 (d, J = 14.4 Hz, 1H), 3.85 (s, 3H), 3.79 (s, 3H), 3.77 (s, 3H), 3.46 (d, J = 11.2 Hz, 1H), 3.12 (d, J = 16.0 Hz, 1H), 3.04 (d, J = 11.1 Hz, 1H), 2.81 (d, J = 16.1 Hz, 1H), 2.44 (s, 3H), 1.51–1.43 (m, 1H); 13C NMR (126 MHz, CDCl3) δ 159.4, 150.0, 149.0, 143.9, 141.7, 137.4, 135.9, 133.3, 132.3, 129.8 (2C), 129.4, 127.9 (2C), 124.4, 121.1, 114.5, 112.7, 108.4, 106.8, 73.5, 64.7, 60.5, 59.8, 56.0, 56.0, 55.3, 38.7, 21.7; HRMS (ESI-TOF) m/z [M + Na]+ calcd for C29H31NNaO6S 544.1770, found 544.1774.
[α]D −55.2 (c 3.19, CHCl3); 1H NMR (500 MHz, CHCl3) δ 7.86 (d, J = 7.7 Hz, 2H), 7.34 (d, J = 7.8 Hz, 2H), 7.10 (s, 1H), 6.64 (s, 1H), 6.57 (s, 1H), 6.51 (s, 1H), 6.34 (s, 1H), 5.35 (s, 1H), 4.29 (d, J = 15.1 Hz, 1H), 4.13 (d, J = 14.4 Hz, 1H), 3.86 (s, 3H), 3.84 (s, 3H), 3.80 (s, 3H), 3.79 (s, 3H), 3.29 (d, J = 11.1 Hz, 1H), 3.06 (d, J = 11.8 Hz, 1H), 3.01 (d, J = 17.2 Hz, 1H), 2.68 (d, J = 16.0 Hz, 1H), 2.42 (s, 3H), 1.93 (s, 3H), 1.82–1.69 (m, 1H); 13C NMR (126 MHz, CHCl3) δ 150.0, 149.1, 148.4, 146.5, 143.7, 141.0, 136.0, 133.1, 132.5, 129.8 (2C), 128.7, 127.9 (2C), 127.3, 123.5, 113.1, 112.6, 108.5, 106.7, 73.3, 64.8, 60.5, 59.7, 56.2, 56.1, 56.0, 55.9, 55.6, 39.2, 21.6; HRMS (ESI-TOF) m/z [M + Na]+ calcd for C31H35NNaO7S 588.2032, found 588.2022.
[α]D −85.7 (c 2.82, CHCl3); 1H NMR (500 MHz, CHCl3) δ 7.86 (d, J = 8.0 Hz, 2H), 7.35 (d, J = 8.0 Hz, 2H), 7.29 (t, J = 7.4 Hz, 2H), 7.25 (d, J = 7.3 Hz, 1H), 7.12 (d, J = 7.6 Hz, 2H), 7.09 (s, 1H), 6.49 (s, 1H), 6.47 (s, 1H), 5.41 (s, 1H), 4.29 (d, J = 14.6 Hz, 3H), 4.12 (d, J = 15.2 Hz, 1H), 3.85 (s, 3H), 3.78 (s, 3H), 3.46 (d, J = 11.2 Hz, 1H), 3.11 (d, J = 16.1 Hz, 1H), 3.01 (d, J = 11.4 Hz, 1H), 2.80 (d, J = 16.1 Hz, 1H), 2.44 (s, 3H), 1.35 (s, 1H); 13C NMR (126 MHz, CHCl3) δ 150.0, 149.0, 143.9, 141.5, 136.0, 135.9, 133.2, 132.2, 129.8 (2C), 128.7 (2C), 128.4 (2C), 127.9 (2C), 127.5, 124.6, 108.3, 106.7, 77.4, 73.5, 64.7, 59.8, 56.1, 56.0, 38.6, 21.7; HRMS (ESI-TOF) m/z [M + Na]+ calcd for C28H29NNaO5S 514.1664, found 514.1659.
[α]D −23.2 (c 0.92, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.84 (d, J = 8.2 Hz, 2H), 7.67 (d, J = 6.5 Hz, 1H), 7.35 (d, J = 7.7 Hz, 2H), 7.27–7.20 (m, 2H), 7.10 (d, J = 6.8 Hz, 1H), 5.45 (qt, J = 6.8, 2.6 Hz, 1H), 5.24 (s, 1H), 4.07 (ddq, J = 15.1, 3.2, 1.7 Hz, 1H), 4.01 (ddd, J = 15.1, 2.5, 1.4 Hz, 1H), 3.07 (d, J = 16.0 Hz, 1H), 3.03 (d, J = 11.0 Hz, 1H), 2.96 (d, J = 16.0 Hz, 1H), 2.93 (d, J = 11.4 Hz, 1H), 2.45 (s, 3H), 1.54 (dt, J = 6.9, 1.6 Hz, 3H), 1.35–1.20 (m, 1H); 13C NMR (126 MHz, CDCl3) δ 143.9, 141.4, 140.9, 140.5, 135.9, 129.9, 128.5, 127.5, 127.4, 126.4, 124.7, 118.8, 70.7, 65.7, 59.7, 50.4, 39.2, 21.7, 14.8; HRMS (ESI-TOF) m/z [M + Na]+ calcd for C21H23NNaO3S 392.1296, found 392.1294.
[α]D +16.4 (c 3.28, CHCl3); 1H NMR (500 MHz, CHCl3) δ 7.81 (d, J = 8.0 Hz, 2H), 7.65 (d, J = 8.3 Hz, 1H), 7.33 (d, J = 7.6 Hz, 2H), 7.29–7.14 (m, 2H), 7.10 (d, J = 8.8 Hz, 1H), 5.27 (s, 1H), 5.01 (t, J = 2.0 Hz, 1H), 4.13 (dd, J = 15.1, 2.3 Hz, 1H), 3.95 (dd, J = 15.1, 1.9 Hz, 1H), 3.11 (d, J = 15.7 Hz, 1H), 3.08 (d, J = 10.8 Hz, 1H), 2.99 (d, J = 16.5 Hz, 1H), 2.96 (d, J = 12.1 Hz, 1H), 2.43 (s, 3H), 1.75–1.68 (m, 1H); 13C NMR (126 MHz, CHCl3) δ 149.2, 144.0, 141.3, 140.8, 135.5, 129.9 (2C), 128.6, 127.6 (2C), 127.5, 126.4, 124.7, 108.3 (t, J = 23.7 Hz), 70.8, 65.2, 59.8, 52.9, 39.0, 21.7; HRMS (ESI-TOF) m/z [M + Na]+ calcd for C20H20DNNaO3S 379.1203, found 379.1196.
[α]D +10.6 (c 3.13, CHCl3); 1H NMR (500 MHz, CHCl3) δ 7.47 (d, J = 8.0 Hz, 1H), 7.31 (d, J = 8.2 Hz, 2H), 7.06–6.99 (m, 3H), 6.87 (t, J = 7.1 Hz, 1H), 6.56 (d, J = 6.8 Hz, 1H), 5.88 (s, 1H), 5.35 (s, 1H), 5.13 (s, 1H), 4.53 (d, J = 12.9 Hz, 1H), 4.11 (d, J = 12.9 Hz, 1H), 2.31 (s, 3H), 1.57 (s, 9H), 1.41–1.14 (m, 13H), 0.93–0.80 (m, 6H), 0.50 (d, J = 13.8 Hz, J119Sn–1H = 54.1 Hz, 1H); 13C NMR (126 MHz, CHCl3) δ 178.8, 147.1, 143.1, 137.7, 137.1, 132.7, 129.4, 129.1 (2C), 127.5, 126.9 (2C), 124.4, 112.6, 87.4, 69.2, 60.3, 52.9, 28.1, 28.0, 27.9 (3C), 27.8, 26.8, 26.7, 22.1, 21.7, 21.5, 19.3, 13.8, 13.7; HRMS (ESI-TOF) m/z [M + Na]+ calcd for C32H45BrClNNaO4SSn 798.0840, found 798.0853.
[α]D +21.7 (c 0.16, CHCl3); 1H NMR (500 MHz, CHCl3) δ 7.53–7.45 (m, 3H), 7.15 (d, J = 7.9 Hz, 2H), 7.11–7.00 (m, 2H), 6.86–6.79 (m, 1H), 5.37 (s, 1H), 5.12 (s, 1H), 5.03 (s, 1H), 4.28 (dt, J = 13.6, 2.4 Hz, 1H), 4.16 (d, J = 13.7 Hz, 1H), 3.42 (dt, J = 10.5, 3.0 Hz, 1H), 3.31 (dd, J = 10.9, 7.6 Hz, 1H), 2.84 (dd, J = 7.9, 3.8 Hz, 1H), 2.37 (s, 3H), 1.72–1.46 (m, 4H), 1.46–1.03 (m, 9H), 0.91 (t, J = 7.3 Hz, 3H), 0.85 (t, J = 7.3 Hz, 3H), 0.54 (dd, J = 13.9, 2.5 Hz, J119Sn–1H = 56.7 Hz, 1H); 13C NMR (126 MHz, CHCl3) δ 147.2, 144.0, 138.8, 138.0, 132.9, 129.7 (2C), 129.4, 128.7, 127.8, 127.5 (2C), 124.3, 112.7, 77.2, 68.0, 67.2, 55.7, 51.7, 28.2, 28.2, 26.9, 26.8, 22.2, 21.6, 19.2, 19.1, 13.8, 13.6; HRMS (ESI-TOF) m/z [M − HCl + Na]+ calcd for C28H38BrNNaO3SSn 690.0675, found 690.0655.
[α]D −77.1 (c 3.18, CHCl3); 1H NMR (500 MHz, CHCl3) δ 7.16–7.09 (m, 4H), 6.99 (d, J = 8.1 Hz, 2H), 6.92 (d, J = 7.3 Hz, 2H), 5.26 (s, 1H), 5.15 (s, 1H), 4.80 (s, 1H), 4.55 (d, J = 3.3 Hz, 1H), 4.36 (d, J = 13.8 Hz, 1H), 3.97 (d, J = 13.8 Hz, 1H), 3.68 (dd, J = 9.9, 4.5 Hz, 1H), 3.37 (dd, J = 9.9, 2.8 Hz, 1H), 2.31 (s, 3H), 1.67–1.46 (m, 4H), 1.39–1.17 (m, 8H), 1.08 (d, J = 13.7 Hz, J119Sn–1H = 48.5 Hz, 1H), 0.92 (t, J = 8.0 Hz, 3H), 0.81 (t, J = 7.4 Hz, 3H), 0.73 (d, J = 13.6 Hz, J119Sn–1H = 70.2 Hz, 1H); 13C NMR (126 MHz, CHCl3) δ 148.0, 143.3, 137.3, 135.1, 129.2 (2C), 128.5 (2C), 128.2, 128.1 (2C), 126.9 (2C), 110.7, 69.6, 68.0, 55.4, 51.0, 28.1, 28.1, 26.9, 26.8, 21.5, 20.7, 20.4, 19.4, 13.7, 13.6; 119Sn NMR (186 MHz, CDCl3) δ 33.3; HRMS (ESI-TOF) m/z [M + H]+ calcd for C28H41ClNO3SSn 626.15176, found 626.15087; Anal. Calcd for C28H40ClNO3SSn: C, 53.82; H, 6.45; N, 2.24. Found: C, 53.76; H, 6.56; N, 2.22.
[α]D −83.6 (c 0.87, CHCl3); 1H NMR (500 MHz, CHCl3) δ 7.21 (t, J = 7.3 Hz, 1H), 7.15–7.11 (m, 4H), 6.99 (d, J = 7.9 Hz, 2H), 6.91 (d, J = 7.1 Hz, 2H), 5.27 (s, 1H), 5.16 (s, 1H), 4.81 (s, 1H), 4.68 (s, 1H), 4.37 (d, J = 13.8 Hz, 1H), 3.97 (d, J = 13.9 Hz, 1H), 3.73 (t, J = 8.6, 3.8 Hz, 1H), 3.37 (d, J = 9.8 Hz, 1H), 2.31 (s, 3H), 1.67–1.47 (m, 4H), 1.40–1.22 (m, 8H), 1.19 (d, J = 14.4 Hz, J119Sn–1H = 73.6 Hz, 1H), 0.92 (t, J = 7.3 Hz, 3H), 0.81 (t, J = 7.7 Hz, 3H), 0.78 (d, J = 14.4 Hz, J119Sn–1H = 50.2 Hz, 1H); 13C NMR (126 MHz, CHCl3) δ 147.9, 143.4, 137.3, 135.0, 129.2 (2C), 128.5 (2C), 128.2 (2C), 128.1, 126.9 (2C), 110.7, 69.5, 68.1, 55.8, 51.0, 28.5 (d, J13C −119Sn = 28.0 Hz), 28.4 (d, J13C–119Sn = 28.0 Hz), 26.8 (d, J13C–119Sn = 82.9 Hz, J13C–117Sn = 80.5 Hz), 26.7 (d, J13C–119Sn = 84.6 Hz, J13C–117Sn = 78.8 Hz), 21.5, 21.0 (d, J13C–119Sn = 435.6 Hz, J13C–117Sn = 416.4 Hz), 20.9 (d, J13C–119Sn = 428.2 Hz, J13C–117Sn = 410.8 Hz), 20.3 (d, J13C–119Sn = 400.0 Hz, J13C–117Sn = 381.4 Hz), 13.7, 13.6; 119Sn NMR (186 MHz, CDCl3) δ 28.8; HRMS (ESI-TOF) m/z [M + Na]+ calcd for C28H40BrNNaO3SSn 692.08319, found 692.08200; Anal. Calcd for C28H40BrNO3SSn: C, 50.25; H, 6.02; N, 2.09. Found: C, 50.45; H, 6.13; N, 1.96.
[α]D −82.5 (c 0.08, CHCl3); 1H NMR (500 MHz, CHCl3) δ 7.19 (t, J = 7.4 Hz, 1H), 7.16–7.08 (m, 4H), 6.97 (d, J = 7.9 Hz, 2H), 6.91 (d, J = 7.7 Hz, 2H), 5.22 (s, 1H), 5.12 (s, 1H), 4.70 (s, 1H), 4.32 (d, J = 13.9 Hz, 1H), 3.95 (d, J = 14.0 Hz, 1H), 3.52 (d, J = 10.3 Hz, 1H), 3.23 (d, J = 10.4 Hz, 1H), 2.30 (s, 3H), 1.91 (s, 1H), 1.67–0.97 (m, 13H), 0.91 (t, J = 7.1 Hz, 3H), 0.85 (t, J = 7.7 Hz, 3H), 0.57 (d, J = 13.7 Hz, J119Sn–1H = 73.2 Hz, 1H); 13C NMR (126 MHz, CHCl3) δ 148.7, 143.1, 138.0, 135.8, 129.3 (2C), 128.5 (2C), 128.4 (2C), 128.2, 127.1 (2C), 110.4, 69.9, 67.9, 55.3, 51.3, 27.9 (2C), 27.1 (2C), 21.6, 19.0, 18.8, 16.6, 13.9 (2C); 119Sn NMR (186 MHz, CDCl3) δ 15.56 (d, J = 2081.5 Hz); 19F NMR (376 MHz, CDCl3) δ −183.8 (d, J = 2052.9 Hz); HRMS (ESI-TOF) m/z [M + Na]+ calcd for C28H40FNNaO3SSn 632.1633, found 632.1626.
[α]D +21.3 (c 0.45, CHCl3); 1H NMR (500 MHz, CHCl3) δ 7.83 (d, J = 7.5 Hz, 2H), 7.75–7.67 (m, 1H), 7.31 (d, J = 9.1 Hz, 2H), 7.28–7.23 (m, 2H), 7.12 (d, J = 6.1 Hz, 1H), 5.80 (s, 1H), 5.29 (s, 1H), 5.09 (s, 1H), 4.17 (dt, J = 14.2, 2.5 Hz, 1H), 3.90 (dt, J = 14.2, 1.8 Hz, 1H), 3.49 (d, J = 16.9 Hz, 1H), 3.22 (d, J = 16.4 Hz, 1H), 2.41 (s, 3H), 1.30 (s, 9H); 13C NMR (126 MHz, CHCl3) δ 160.8, 147.4, 143.5, 140.9, 139.7, 136.1, 129.7 (2C), 128.7, 127.9 (2C), 127.8, 126.5, 124.4, 109.8, 81.9, 72.7, 63.5, 53.0, 41.2, 27.7 (3C), 21.6; HRMS (ESI-TOF) m/z [M + Na]+ calcd for C24H27NNaO4S 448.1559, found 448.1560.
Mp 165.0–166.0 °C; [α]D +15.8 (c 1.02, CHCl3); 1H NMR (500 MHz, CHCl3) δ 7.83 (d, J = 8.2 Hz, 2H), 7.68–7.62 (m, 1H), 7.34 (d, J = 8.0 Hz, 2H), 7.28–7.20 (m, 2H), 7.11 (d, J = 6.6 Hz, 1H), 5.27 (s, 1H), 5.08 (t, J = 2.2 Hz, 1H), 5.04 (s, 1H), 4.15 (ddd, J = 15.1, 3.2, 1.5 Hz, 1H), 4.00–3.93 (m, 1H), 3.14–3.06 (m, 2H), 3.00 (t, J = 10.4 Hz, 2H), 2.44 (s, 3H), 1.71–1.61 (m, 1H); 13C NMR (126 MHz, CHCl3) δ 149.4, 144.0, 141.3, 140.7, 135.6, 129.9 (2C), 128.6, 127.7 (2C), 127.5, 126.4, 124.7, 108.4, 70.8, 65.3, 59.9, 52.9, 39.1, 21.7; HRMS (ESI-TOF) m/z [M + Na]+ calcd for C20H21NNaO3S 378.1140, found 378.1129.
Footnote |
† Electronic supplementary information (ESI) available: NMR for compounds 2, 4, 5, 6, and 7, and an ORTEP chart for 6e. CCDC 845991. For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/c6ob01018k |
This journal is © The Royal Society of Chemistry 2016 |